Tumor Microenvironment Stimuli-Responsive Single-NIR-Laser Activated Synergistic Phototherapy for Hypoxic Cancer by...

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Synergistic cancer therapy faces limitations like wavelength mismatch, tumor hypoxia, and photosensitizer leakage.
• Existing treatments struggle with intelligent on-demand activation and efficient drug delivery.

Purpose of the Study:

• To develop a tumor microenvironment (TME) stimuli-responsive and dual-targeted composite nanoplatform (UCTTD-PC4) for enhanced cancer treatment.
• To address limitations of photothermal and photodynamic therapies by creating a single near-infrared laser-triggered system.

Main Methods:

• Fabrication of UCTTD-PC4 by coating tannic acid (TA)/Fe3+ nanofilm onto upconversion nanoparticles.
• Utilizing TME characteristics (acidity, hypoxia, H2O2) for stimuli-responsive Fe3+ release and oxygen generation.
• Achieving spectral matching between upconversion nanoparticles and photosensitizer (PC4) for synergistic effects.

Main Results:

• UCTTD-PC4 demonstrated pH-responsive Fe3+ release in acidic tumor cells, catalyzing H2O2 to produce O2 and alleviate tumor hypoxia.
• The emission spectrum of UCTTD perfectly matched the absorption spectrum of PC4, enabling enhanced therapeutic effects with a single laser.
• The nanoplatform showed stability during circulation and effective dual-targeting capabilities.

Conclusions:

• The developed UCTTD-PC4 nanoplatform offers a promising strategy for safe and efficient synergistic cancer therapy.
• This approach effectively overcomes tumor hypoxia and enhances therapeutic efficacy through intelligent, on-demand activation.
• The study provides a new paradigm for designing advanced nanomedicine platforms for multimodal imaging-guided cancer treatment.